Bausch Health Companies (TSE:BHC) Trading Down 2.3% – Time to Sell?

Bausch Health Companies Inc. (TSE:BHC) shares fell 2.3% on Friday . The company traded as low as C$6.77 and last traded at C$6.78. Approximately 292,697 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 477,546 shares. The stock had previously closed at C$6.94.

Bausch Health Companies Stock Performance

The firm has a market cap of C$2.53 billion, a P/E ratio of -2.09, a PEG ratio of 0.21 and a beta of 0.97. The company has a current ratio of 1.32, a quick ratio of 0.58 and a debt-to-equity ratio of -1,009.96. The company’s 50-day moving average is C$7.12 and its two-hundred day moving average is C$7.79.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported C$1.08 EPS for the quarter. The firm had revenue of C$3.51 billion during the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%. As a group, equities analysts predict that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.